Treatment duration varies
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, representing a related but distinct medication class
Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating
There has been extensive preclinical in vitro and in vivo research showing the relationship between metals such as copper, zinc, and iron and the onset and progression of neurodegenerative conditions such as Alzheimers disease
Semaglutide is typically administered as a once-weekly injection and has been shown to be effective in improving blood sugar control, promoting weight loss, and reducing cardiovascular risks in people with type 2 diabetes
A metabolic panel about every six months it shows how your body is responding so your provider can fine-tune your plan